AIG
AXDX

American International Group’s Accelerate Diagnostics AXDX Stock Holding History

American International Group’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,638
Closed -$24K – 3103
2022
Q1 		$24K Sell
1,638
-115
-7% -$3.27K ﹤0.01% 3001
2021
Q4 		$92K Sell
1,753
-53
-3% -$2.95K ﹤0.01% 2751
2021
Q3 		$105K Sell
1,806
-42
-2% -$2.74K ﹤0.01% 2784
2021
Q2 		$149K Sell
1,848
-65
-3% -$5.17K ﹤0.01% 2689
2021
Q1 		$159K Buy
1,913
+83
+5% +$8.42K ﹤0.01% 2488
2020
Q4 		$139K Sell
1,830
-30
-2% -$2.69K ﹤0.01% 2479
2020
Q3 		$198K Sell
1,860
-5
-0.3% -$694 ﹤0.01% 2150
2020
Q2 		$283K Buy
1,865
+250
+15% +$24.6K ﹤0.01% 1919
2020
Q1 		$135K Sell
1,615
-93
-5% -$13.1K ﹤0.01% 2131
2019
Q4 		$289K Sell
1,708
-14
-0.8% -$2.31K ﹤0.01% 1995
2019
Q3 		$320K Sell
1,722
-12
-0.7% -$2.32K ﹤0.01% 1905
2019
Q2 		$397K Buy
1,734
+72
+4% +$14.1K ﹤0.01% 1826
2019
Q1 		$349K Sell
1,662
-54
-3% -$10.1K ﹤0.01% 1902
2018
Q4 		$197K Sell
1,716
-14
-0.8% -$2.07K ﹤0.01% 2192
2018
Q3 		$397K Buy
1,730
+32
+2% +$7.08K ﹤0.01% 2026
2018
Q2 		$379K Buy
1,698
+14
+0.8% +$3.13K ﹤0.01% 2005
2018
Q1 		$385K Sell
1,684
-71
-4% -$18.6K ﹤0.01% 1891
2017
Q4 		$460K Buy
1,755
+8
+0.5% +$1.88K ﹤0.01% 1840
2017
Q3 		$392K Buy
1,747
+131
+8% +$32.2K ﹤0.01% 1897
2017
Q2 		$442K Buy
1,616
+197
+14% +$53.4K ﹤0.01% 1789
2017
Q1 		$343K Buy
1,419
+94
+7% +$21.5K ﹤0.01% 1855
2016
Q4 		$275K Sell
1,325
-3
-0.2% -$712 ﹤0.01% 1987
2016
Q3 		$362K Buy
1,328
+2
+0.2% +$442 ﹤0.01% 1800
2016
Q2 		$191K Buy
1,326
+66
+5% +$8.85K ﹤0.01% 2153
2016
Q1 		$181K Hold
1,260
– – ﹤0.01% 2869
2015
Q4 		$271K Sell
1,260
-2
-0.2% -$365 ﹤0.01% 2532
2015
Q3 		$204K Buy
1,262
+1
+0.1% +$216 ﹤0.01% 2807
2015
Q2 		$325K Sell
1,261
-167
-12% -$39.9K ﹤0.01% 2568
2015
Q1 		$321K Hold
1,428
– – ﹤0.01% 2540
2014
Q4 		$274K Sell
1,428
-56
-4% -$12K ﹤0.01% 2679
2014
Q3 		$319K Sell
1,484
-1
-0.1% -$194 ﹤0.01% 2529
2014
Q2 		$386K Buy
1,485
+732
+97% +$160K ﹤0.01% 2390
2014
Q1 		$164K Sell
753
-482
-39% -$71.4K ﹤0.01% 3013
2013
Q4 		$151K Buy
1,235
+538
+77% +$71.9K ﹤0.01% 3013
2013
Q3 		$93.4K Buy
+697
New +$62.2K ﹤0.01% 3368

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return

American International Group's AXDX Position: Q2 2022 in Review

American International Group sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 1,638 shares — an estimated $24K sold.

American International Group first reported a position in AXDX in Q3 2013 and held it in 35 quarters. The position peaked at $460K in Q4 2017. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.

  • American International Group reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 1,638 Accelerate Diagnostics shares in Q2 2022, an estimated $24K.
  • American International Group first reported a position in Accelerate Diagnostics in Q3 2013 and held it in 35 quarters.
  • American International Group's Accelerate Diagnostics position peaked at $460K in Q4 2017.
  • 74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.